This new report from the Deloitte UK Centre for Health Solutions considers the current market access and pricing challenges presented by the European market, and provides recommendations on how pharma companies can work more collaboratively with payers to help patients gain access to the latest medical innovations.
The reports considers the following market access challenges:
To ensure continued market access, the report recommends that pharma should develop the following organisational capabilities: